Resveratrol compared to Placebo for bone mineral density in human | ||||
---|---|---|---|---|
Patient or population: Adults Setting: Intervention: Resveratrol Comparison: Placebo | ||||
Outcome № of participants (studies) | Anticipated absolute effects (95% CI) | Certainty | ||
Without resveratrol | With resveratrol | Difference | ||
BMD at lumbar spine assessed with: dual-energy X-ray absorptiometryfollow up: range 16 weeks to 12 months № of participants: 370 (3 RCTs) | The mean BMD at lumbar spine was 1.04–1.073 | – | MD 0.02 lower (0.05 lower to 0.01 higher) | ⨁◯◯◯ VERY LOW a,b,c |
Serum PINP follow up: range 4 weeks to 16 weeks № of participants: 90 (2 RCTs) | The mean serum PINP ranged from 8.6–41.3 | – | MD 2.92 lower (6.33 lower to 0.5 higher) | ⨁◯◯◯ VERY LOW a,b,d |